Hemiplegia

G6_HEMIPLE

hemiplegia: Severe or complete loss of motor function on one side of the body. This condition is usually caused by brain diseases that are localized to the cerebral hemisphere opposite to the side of weakness. Less frequently, brain stem lesions; cervical spinal cord diseases; peripheral nervous system diseases; and other conditions may manifest as hemiplegia. The term hemiparesis (see paresis) refers to mild to moderate weakness involving one side of the body. [ MESH:D006429 ]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G81 Hospital discharge: ICD-9 — 342 Hospital discharge: ICD-8 — 34400 Cause of death: ICD-10 — G81 Cause of death: ICD-9 — 342 Cause of death: ICD-8 — 34400 2 out of 7 registries used, show all original rules.	2086
4. Check minimum number of events None	2086
5. Include endpoints None	2086
6. Filter based on genotype QC (FinnGen only)	2086

Control definitions (FinnGen only)

Control exclude: G6_CPETAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G80-G83
Name in latin: Hemiplegia

NAME	G6_HEMIPLE
CONTROL_EXCLUDE	G6_CPETAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G81
HD_ICD_9	342
HD_ICD_8	34400
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G81
COD_ICD_9	342
COD_ICD_8	34400
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hemiplegia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	26668	13097	13007
Only index persons	15147	8058	7089
Unadjusted period prevalence (%)
Whole population	0.37	0.38	0.36
Only index persons	0.28	0.30	0.27
Median age at first event (years)
Whole population	62.63	63.06	61.95
Only index persons	52.30	51.17	53.58

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2086	1114	972
Unadjusted period prevalence (%)	0.40	0.38	0.43
Median age at first event (years)	52.37	46.25	59.37

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1921: Matched controls
19221

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G81.9

ICD-10 Finland

Hemiplegia, unspecified

10943.9

323.0

1466

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

7.8

246.6

656

1198

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

7.8

184.3

470

765

34400

ICD-8 Finland

Other cerebral paralysis, Hemiplegia NUD

+∞

168.2

159

AA1AD

NOMESCO Finland

CT of head and brain

4.3

164.6

794

2696

G81.1

ICD-10 Finland

Spastic hemiplegia

391.2

147.1

146

3429X

ICD-9 Finland

Hemiplegia, unspecified

+∞

132.9

126

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

6.3

128.7

380

728

G81.0

ICD-10 Finland

Flaccid hemiplegia

1176.0

114.9

111

XF400

NOMESCO Finland

ECG with 12 standard connections

3.6

102.5

555

1926

R20.2

ICD-10 Finland

Paraesthesia of skin

5.9

91.2

277

535

R51.80

ICD-10 Finland

Headache

3.8

90.4

450

1439

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.0

86.7

304

692

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

6.5

84.9

236

405

R4120

NOMESCO Finland

Occupational therapy

5.8

81.8

248

475

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.0

81.6

286

648

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

4.9

77.0

275

634

N03AX12

ATC

gabapentin; oral

3.4

74.9

427

1495

XA800

NOMESCO Finland

Neuropsychological investigation

6.9

73.7

195

311

R4110

NOMESCO Finland

Physiotherapy

2.7

70.5

640

3034

N03AX16

ATC

pregabalin; oral

2.8

69.8

580

2604

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

4.3

69.1

283

745

M03BX01

ATC

baclofen; systemic

15.4

69.0

116

TAB00

NOMESCO Finland

Lumbar puncture

6.3

68.4

193

335

N18

ICPC

Paralysis/weakness

12.0

68.0

128

114

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

5.9

67.4

199

366

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

5.4

67.0

215

437

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.0

65.0

448

1776

R42

ICD-10 Finland

Dizziness and giddiness

2.7

63.3

552

2527

R56.8

ICD-10 Finland

Other and unspecified convulsions

5.1

57.5

193

411

N05BA01

ATC

diazepam; systemic, rectal

3.0

55.3

366

1395

G40.9

ICD-10 Finland

Epilepsy, unspecified

6.4

55.0

152

255

N03AF02

ATC

oxcarbazepine; oral

6.7

54.5

145

231

N03AX09

ATC

lamotrigine; oral

5.4

54.5

173

345

N02AX02

ATC

tramadol; systemic, rectal

2.1

53.5

893

5537

N03AF01

ATC

carbamazepine; oral, rectal

4.7

53.4

194

449

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

4.5

53.2

204

498

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

51.8

668

3674

R53

ICD-10 Finland

Malaise and fatigue

2.5

51.1

507

2444

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

50.7

475

2218

N03AG01

ATC

valproic acid; systemic, rectal

4.2

48.2

198

515

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.5

48.1

247

778

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

47.9

747

4433

N03AE01

ATC

clonazepam; systemic

4.2

47.2

192

495

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.0

46.6

304

1138

N06AB04

ATC

citalopram; systemic

2.3

46.0

501

2512

N06AX21

ATC

duloxetine; oral

3.2

45.7

268

932

B01AC07

ATC

dipyridamole; systemic

3.9

45.3

203

571

N03AX11

ATC

topiramate; oral

7.3

44.3

110

159

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.6

44.1

376

1651

G43.9

ICD-10 Finland

Migraine, unspecified

4.3

44.0

174

436

WX892

NOMESCO Finland

Monitored bed care

3.6

43.9

217

661

K90

ICPC

Stroke/cerebrovascular accident

6.3

43.6

120

200

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

+∞

42.9

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

+∞

42.9

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

42.8

836

5367

M79.6

ICD-10 Finland

Pain in limb

2.1

42.7

705

4232

L28

ICPC

Limited function/disability (L)

2.5

42.7

375

1672

N06AA09

ATC

amitriptyline; systemic

3.0

41.0

260

950

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.9

40.8

141

308

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.7

40.6

145

328

TKC20

NOMESCO Finland

Catheterisation of bladder

3.4

40.3

214

688

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

39.4

316

1335

G44.2

ICD-10 Finland

Tension-type headache

2.7

39.0

304

1261

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.1

38.9

236

835

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.7

38.6

182

532

R06.0

ICD-10 Finland

Dyspnoea

2.1

38.3

524

2880

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.1

38.2

230

807

N06AX11

ATC

mirtazapine; oral

2.0

37.7

635

3794

S06.0

ICD-10 Finland

Concussion

2.8

37.5

263

1020

R55

ICD-10 Finland

Syncope and collapse

2.7

37.2

277

1117

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

6.2

37.2

104

177

N05AH04

ATC

quetiapine; oral

2.4

36.5

363

1715

A28

ICPC

Limited function/disability NOS

2.4

36.3

352

1642

N06AX16

ATC

venlafaxine; oral

2.6

36.3

295

1251

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

34.6

553

3216

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.5

34.5

309

1380

G43.3

ICD-10 Finland

Complicated migraine

8.5

34.1

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

7.0

33.7

126

N05CF01

ATC

zopiclone; oral

1.9

33.2

672

4257

AA5PD

NOMESCO Finland

CT examination of brain pefusion

12.9

33.1

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.6

32.5

258

1074

N03AX14

ATC

levetiracetam; systemic

5.6

32.4

180

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.8

32.4

145

405

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

32.3

428

2296

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

16.2

32.1

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.6

31.4

128

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

6.4

31.3

136

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

31.2

573

3486

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

6.6

31.2

129

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

31.1

378

1945

B01AC04

ATC

clopidogrel; oral

2.3

30.9

340

1674

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

30.8

326

1576

R1250

NOMESCO Finland

Evaluation of functional capability

6.5

30.5

129

M54.5

ICD-10 Finland

Low back pain

1.9

30.2

613

3858

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

7.9

30.1

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

29.8

332

1640

N28

ICPC

Limited function/disability (N)

7.6

29.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

29.7

350

1775

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

29.6

521

3111

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.6

29.6

105

236

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

29.4

334

1667

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

28.6

353

1825

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

28.5

313

1534

A06AD11

ATC

lactulose; oral

2.1

28.4

350

1808

N02AA05

ATC

oxycodone; systemic

2.2

27.7

310

1534

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

27.5

209

844

M03BC01

ATC

orphenadrine (citrate); systemic

2.0

27.4

439

2517

N05BA04

ATC

oxazepam; oral

1.9

27.4

499

2999

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.2

27.2

107

266

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

27.0

359

1912

G35

ICD-10 Finland

Multiple sclerosis

6.6

26.9

109

A02BC02

ATC

pantoprazole; systemic

1.7

26.9

1159

9089

SPAT1229

SPAT

Assessment of need for aid

2.7

26.6

194

764

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

26.6

231

1006

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

9.4

26.5

183

Kela drug reimbursment

Lamotrigin and topiramate

9.7

26.5

N03AB02

ATC

phenytoin; systemic

9.0

26.3

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.7

26.2

198

797

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

26.2

361

1950

H53.1

ICD-10 Finland

Subjective visual disturbances

3.0

25.4

151

523

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.7

25.4

184

723

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

8.9

25.3

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

25.3

180

700

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

5.6

25.2

139

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.6

25.2

119

348

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.9

25.1

158

567

3431A

ICD-9 Finland

Infantile cerebral palsy, Hemiplegic

+∞

25.0

G43.8

ICD-10 Finland

Other migraine

7.6

25.0

N05CD07

ATC

temazepam; oral

2.1

24.9

307

1577

H53.4

ICD-10 Finland

Visual field defects

5.2

24.6

156

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

9.0

24.6

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

7.5

24.5

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

8.1

24.3

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

7.2

24.2

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

11.8

24.0

N30.0

ICD-10 Finland

Acute cystitis

2.1

24.0

286

1447

N06AB10

ATC

escitalopram; oral

2.0

23.9

373

2103

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

23.8

349

1926

J01MA02

ATC

ciprofloxacin; systemic

1.7

23.5

727

5118

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.7

23.4

104

289

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.9

23.4

115

M54.1

ICD-10 Finland

Radiculopathy

3.7

23.3

104

290

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.3

23.3

123

392

R51

ICD-10 Finland

Headache

3.4

23.2

118

366

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.7

23.1

105

298

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

23.1

151

557

G82.2

ICD-10 Finland

Paraplegia, unspecified

+∞

23.0

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

5.8

22.9

118

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.9

22.8

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.5

22.8

127

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

5.6

22.7

123

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

121.5

22.6

N06AB03

ATC

fluoxetine; oral

2.2

22.6

253

1243

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

8.3

22.5

J01EA01

ATC

trimethoprim; systemic

1.8

22.2

503

3217

C03CA01

ATC

furosemide; systemic

1.7

22.2

594

3997

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

22.2

221

1030

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

22.1

402

2393

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

21.7

306

1657

R11

ICD-10 Finland

Nausea and vomiting

2.5

21.6

172

714

J01FF01

ATC

clindamycin; systemic

1.8

21.6

487

3108

R02

ICPC

Shortness of breath/dyspnoea

2.2

20.9

229

1113

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.4

20.9

181

R52.2

ICD-10 Finland

Other chronic pain

4.1

20.8

210

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

20.8

377

2234

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

20.8

473

3020

N05BA09

ATC

clobazam; oral

13.7

20.5

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

20.3

698

5005

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

8.0

20.3

H53.2

ICD-10 Finland

Diplopia

4.1

20.2

206

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.5

20.2

162

671

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

20.2

797

5917

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.9

20.2

130

474

315

Kela drug reimbursment

Clopidogrel

7.2

20.2

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

20.1

163

683

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.0

20.1

120

417

M25.5

ICD-10 Finland

Pain in joint

1.7

19.9

484

3148

C10AA05

ATC

atorvastatin; oral

1.6

19.8

630

4418

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.8

19.7

145

F60.9

ICD-10 Finland

Personality disorder, unspecified

7.1

19.7

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

19.6

273

1467

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

5.0

19.5

129

N99

ICPC

Neurological disease other

7.2

19.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

19.4

372

2246

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

19.3

117

411

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.2

19.3

181

L17

ICPC

Foot/toe symptom/complaint

1.7

19.3

433

2744

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.3

19.3

182

824

K91

ICPC

Cerebrovascular disease

6.2

19.3

H02AB06

ATC

prednisolone; systemic

1.6

19.1

831

6291

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.7

19.1

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

14.1

19.1

F44.4

ICD-10 Finland

Dissociative motor disorders

34.7

18.9

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

9.7

18.9

XCK00

NOMESCO Finland

Perimetry

2.5

18.8

154

648

N06AX03

ATC

mianserin; oral

2.9

18.7

115

409

N05AA02

ATC

levomepromazine; systemic

3.1

18.6

105

351

R50.9

ICD-10 Finland

Fever, unspecified

2.0

18.5

271

1483

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.1

18.5

184

R13

ICD-10 Finland

Dysphagia

2.6

18.4

142

576

I63.8

ICD-10 Finland

Other cerebral infarction

9.2

18.4

S80.0

ICD-10 Finland

Contusion of knee

2.6

18.2

135

537

G40.10

ICD-10 Finland

Simple partial seizures

8.6

18.2

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

6.5

18.1

J46

ICD-10 Finland

Status asthmaticus

3.9

18.0

198

R51.81

ICD-10 Finland

Facial pain NOS

4.8

18.0

128

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.5

18.0

245

R47.1

ICD-10 Finland

Dysarthria and anarthria

8.4

18.0

M03BX02

ATC

tizanidine; oral

1.5

17.9

1033

8307

J20

ICD-10 Finland

Acute bronchitis

2.2

17.8

184

867

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.7

17.7

212

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

9.9

17.6

R33

ICD-10 Finland

Retention of urine

2.3

17.6

178

831

N05AH03

ATC

olanzapine; systemic

2.8

17.6

119

447

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.5

17.6

145

I63

ICD-10 Finland

Cerebral infarction

8.9

17.2

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

17.1

166

762

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

17.6

16.9

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

8.2

16.8

ZXA05

NOMESCO Finland

Left side

1.7

16.7

451

2998

G83.1

ICD-10 Finland

Monoplegia of lower limb

+∞

16.7

G83.4

ICD-10 Finland

Cauda equina syndrome

35.4

16.7

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

8.0

16.6

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

171.4

16.5

A01

ICPC

Pain general/multiple sites

2.4

16.5

142

612

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.1

16.4

318

G04BD04

ATC

oxybutynin; oral, transdermal

2.5

16.3

129

530

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

7.2

16.3

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

5.0

16.3

106

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

16.3

960

7688

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.9

16.2

111

A02BC05

ATC

esomeprazole; systemic

1.5

16.2

694

5176

M89.0

ICD-10 Finland

Algoneurodystrophy

9.8

16.2

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

16.1

137

587

X58

ICD-10 Finland

Exposure to other specified factors

1.9

16.1

239

1312

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

16.1

695

5193

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.3

16.0

263

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

16.0

483

3304

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

16.0

121

488

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

16.0

190

956

SPAT1254

SPAT

Administration of medicine

1.9

15.9

268

1539

N01

ICPC

Headache

2.1

15.9

178

871

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.1

15.8

293

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.6

15.8

123

N06AB06

ATC

sertraline; oral

2.1

15.8

197

1008

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.2

15.8

B01AA03

ATC

warfarin; systemic

1.7

15.8

405

2651

G82.1

ICD-10 Finland

Spastic paraplegia

+∞

15.6

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.3

15.6

145

650

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

15.5

388

2522

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.1

15.4

177

877

R52.0

ICD-10 Finland

Acute pain

3.5

15.4

206

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

15.3

193

992

M79.1

ICD-10 Finland

Myalgia

1.9

15.3

223

1216

C08CA01

ATC

amlodipine; oral

1.5

15.2

580

4191

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

13.2

15.2

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

7.6

15.2

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

15.1

125

529

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

6.7

15.1

D01

ICPC

Abdominal pain/cramps general

2.1

15.1

184

935

R60.0

ICD-10 Finland

Localized oedema

2.0

15.1

210

1124

W19

ICD-10 Finland

Unspecified fall

2.1

15.0

180

907

Z71.8

ICD-10 Finland

Other specified counselling

1.7

14.9

391

2567

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.9

14.9

160

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.5

14.9

120

499

T78.4

ICD-10 Finland

Allergy, unspecified

2.8

14.9

345

X57

ICD-10 Finland

Unspecified privation

4.1

14.8

146

C10AA01

ATC

simvastatin; oral

1.5

14.8

707

5371

H02AB07

ATC

prednisone; oral

1.8

14.8

279

1660

N05BA12

ATC

alprazolam; oral

2.0

14.8

191

991

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

14.7

150

705

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.0

14.7

147

M54.3

ICD-10 Finland

Sciatica

2.5

14.7

122

515

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.7

14.7

315

1951

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.0

14.7

285

A04

ICPC

Weakness/tiredness general

1.9

14.6

231

1296

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.7

14.6

106

M54.2

ICD-10 Finland

Cervicalgia

2.3

14.6

134

599

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.9

14.6

158

WX002

NOMESCO Finland

Sedation and analgesia

1.7

14.5

331

2090

C07AB07

ATC

bisoprolol; oral

1.5

14.5

814

6394

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.0

14.5

G81

ICD-10 Finland

Hemiplegia

151.1

14.5

N03AX18

ATC

lacosamide; systemic

9.5

14.4

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

14.3

592

4353

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.8

14.2

338

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

14.2

292

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

14.2

418

2827

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

6.5

14.2

G44.0

ICD-10 Finland

Cluster headache syndrome

6.5

14.2

R07.3

ICD-10 Finland

Other chest pain

2.1

14.1

175

895

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

14.1

219

1217

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4.3

14.1

124

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

14.1

244

1409

R52.9

ICD-10 Finland

Pain, unspecified

2.2

14.1

154

744

J01DA01

ATC

[U] cefalexin; systemic

1.5

14.1

1121

9424

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

14.1

100

390

A02BC03

ATC

lansoprazole; oral

1.5

14.1

512

3651

L12

ICPC

Hand/finger symptom/complaint

1.8

14.0

240

1382

R4130

NOMESCO Finland

Speech therapy

4.0

14.0

144

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

14.0

134

608

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.9

14.0

306

A02BC01

ATC

omeprazole; systemic

1.6

14.0

494

3498

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.9

13.9

N02BE01

ATC

paracetamol; systemic, rectal

1.5

13.9

1494

13355

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

13.8

202

1100

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.4

13.8

115

490

XF404

NOMESCO Finland

Ambulatory ECG

2.0

13.8

174

896

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

13.7

147

704

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.9

13.7

147

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

13.7

3430A

ICD-9 Finland

Infantile cerebral palsy, Diplegic

+∞

13.6

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

+∞

13.6

J01FA06

ATC

roxithromycin; oral

1.5

13.4

694

5332

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

13.4

469

3310

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

7.1

13.3

43399

ICD-8 Finland

Cerebral thrombosis, Without mention of hypertension

11.6

13.3

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.6

13.3

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

13.2

219

1247

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

13.2

131

606

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

3.0

13.2

253

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

13.1

354

2338

M01AE02

ATC

naproxen; oral, rectal

1.4

13.0

944

7745

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.7

12.9

G91.1

ICD-10 Finland

Obstructive hydrocephalus

13.1

12.9

A02BA02

ATC

ranitidine; systemic

1.6

12.9

361

2404

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

12.9

171

898

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.9

12.8

136

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

12.8

353

R03AC02

ATC

salbutamol; inhalant

1.4

12.8

877

7104

F61.0

ICD-10 Finland

Mixed personality disorders

4.7

12.8

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.6

12.8

372

205

Kela drug reimbursment

Chronic hypertension

1.5

12.8

500

3611

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.8

12.7

314

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

12.6

100

413

N89

ICPC

Migraine

3.4

12.6

180

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

12.6

363

2435

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

12.5

188

1034

G83.2

ICD-10 Finland

Monoplegia of upper limb

130.8

12.4

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

12.4

384

2620

N05AX08

ATC

risperidone; systemic

2.0

12.4

155

794

UKC02

NOMESCO Finland

Cystoscopy

1.7

12.4

298

1905

R25.2

ICD-10 Finland

Cramp and spasm

3.8

12.3

141

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

12.3

256

1568

H57.1

ICD-10 Finland

Ocular pain

3.3

12.3

194

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

12.3

186

1024

109

Kela drug reimbursment

Multiple sclerosis

5.2

12.3

S70.0

ICD-10 Finland

Contusion of hip

2.7

12.3

320

C01CA24

ATC

epinephrine; parenteral

2.3

12.2

113

508

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.7

12.2

321

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.8

12.2

297

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

12.2

120

555

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

12.2

107

469

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

12.0

441

3132

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.4

12.0

176

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

6.3

12.0

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.3

12.0

182

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

11.9

401

2789

ZX120

NOMESCO Finland

Intravenous

2.0

11.9

166

888

N05CF02

ATC

zolpidem; oral

1.7

11.9

280

1777

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

11.9

141

708

C07AA05

ATC

propranolol; systemic

1.6

11.9

314

2057

3AX01

NOMESCO Finland

11.8

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

4.1

11.8

112

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

11.8

390

2703

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.4

11.8

H47.2

ICD-10 Finland

Optic atrophy

10.6

11.8

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

4.1

11.7

108

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.5

11.7

153

J45

ICD-10 Finland

Asthma

1.9

11.7

166

893

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

11.7

290

1866

C09AA05

ATC

ramipril; oral

1.5

11.7

401

2803

F41.00

ICD-10 Finland

Moderate panic disorder

4.5

11.6

N05AX12

ATC

aripiprazole; systemic

2.8

11.6

266

ZXA00

NOMESCO Finland

Right side

1.5

11.6

453

3261

XF620

NOMESCO Finland

Examination of circulation with color method

11.2

11.5

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

11.5

176

973

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.6

11.4

328

G40

ICD-10 Finland

Epilepsy

6.7

11.4

B01AB05

ATC

enoxaparin; parenteral

1.5

11.4

472

3438

G83.3

ICD-10 Finland

Monoplegia, unspecified

120.7

11.4

G41.9

ICD-10 Finland

Status epilepticus, unspecified

7.5

11.4

P01AB01

ATC

metronidazole; oral, rectal

1.4

11.4

644

4994

K59.0

ICD-10 Finland

Constipation

2.2

11.4

119

565

RS220

NOMESCO Finland

5.1

11.4

RS221

NOMESCO Finland

4.3

11.4

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.7

11.4

305

ZX114

NOMESCO Finland

Intramuscular

4.5

11.3

R74

ICPC

Upper respiratory infection acute

1.5

11.3

419

2980

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

11.3

134

674

EB1WA

NOMESCO Finland

9.7

11.2

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

11.2

127

624

N86

ICPC

Multiple sclerosis

7.3

11.2

S22.3

ICD-10 Finland

Fracture of rib

2.2

11.2

116

550

XKD06

NOMESCO Finland

Physiologic investigation of micturition

3.0

11.2

218

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.6

11.2

138

R47.0

ICD-10 Finland

Dysphasia and aphasia

4.8

11.2

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.2

11.2

181

AA9PW

NOMESCO Finland

25.2

11.1

R06AE07

ATC

cetirizine; oral

1.4

11.1

688

5422

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.9

11.1

163

888

K92.0

ICD-10 Finland

Haematemesis

3.0

11.1

213

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

5.8

11.0

L86

ICPC

Back syndrome with radiating pain

2.3

11.0

439

N29

ICPC

Neurological sympt/complt other

4.0

11.0

110

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

4.9

11.0

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.7

11.0

275

R4150

NOMESCO Finland

Neuropsychological rehabilitation

6.7

11.0

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.8

10.9

252

R25.1

ICD-10 Finland

Tremor, unspecified

3.0

10.9

201

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

10.8

614

4755

WX110

NOMESCO Finland

Local anesthesy

1.4

10.8

1101

9458

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

10.8

437

3164

SPAT1234

SPAT

Support of social functional capacity

2.3

10.8

439

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

2.2

10.8

108

506

R40.2

ICD-10 Finland

Coma, unspecified

6.2

10.7

F34.1

ICD-10 Finland

Dysthymia

2.9

10.7

220

SPAT1262

SPAT

Handing over of treatment supplies

1.6

10.7

285

1864

G44.8

ICD-10 Finland

Other specified headache syndromes

5.4

10.7

Z00.0

ICD-10 Finland

General medical examination

1.6

10.7

294

1943

C07AB02

ATC

metoprolol; systemic

1.5

10.7

378

2654

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.6

10.7

133

P16

ICPC

Acute alcohol abuse

4.3

10.7

P03

ICPC

Feeling depressed

2.0

10.7

136

702

W10

ICD-10 Finland

Fall on and from stairs and steps

2.4

10.7

393

M79.7

ICD-10 Finland

Fibromyalgia

2.8

10.7

237

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

10.6

138

719

G83.8

ICD-10 Finland

Other specified paralytic syndromes

60.3

10.6

F43.29

ICD-10 Finland

Adaptation disorder UNS

3.7

10.6

124

M48.0

ICD-10 Finland

Spinal stenosis

1.8

10.6

200

1186

30180

ICD-8 Finland

Personality disorders, Immatura

11.3

10.5

N06AA10

ATC

nortriptyline; systemic

3.5

10.5

135

L16

ICPC

Ankle symptom/complaint

1.9

10.5

162

900

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

5.4

10.4

SPAT1240

SPAT

Therapeutic discussion

1.9

10.4

161

895

J01DA06

ATC

[U] cefuroxime; systemic

1.6

10.3

251

1604

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.7

10.3

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

7.1

10.3

G41.0

ICD-10 Finland

Grand mal status epilepticus

18.9

10.3

3460A

ICD-9 Finland

Migraine, Classical migraine

18.9

10.3

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.7

10.2

264

XX3XW

NOMESCO Finland

7.5

10.2

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.9

10.2

211

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

10.1

215

1324

N07BB01

ATC

disulfiram; oral

2.5

10.1

303

G50.0

ICD-10 Finland

Trigeminal neuralgia

4.1

10.0

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.4

10.0

A46

ICD-10 Finland

Erysipelas

1.7

10.0

226

1416

EBA10

NOMESCO Finland

Surgical removal of tooth

1.8

9.9

172

992

UJF32

NOMESCO Finland

Coloscopy

1.5

9.9

405

2931

P29

ICPC

Psychological sympt/compl other

2.4

9.9

375

R35

ICD-10 Finland

Polyuria

2.1

9.9

111

545

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

9.9

118

596

N05BE01

ATC

buspirone; oral

3.0

9.9

181

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

9.9

106

511

C09CA06

ATC

candesartan; oral

1.5

9.9

323

2225

J04.0

ICD-10 Finland

Acute laryngitis

2.9

9.9

210

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

12.2

9.8

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

9.8

280

1865

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

4.7

9.8

H53.9

ICD-10 Finland

Visual disturbance, unspecified

3.0

9.8

191

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

9.8

509

3867

N06AA12

ATC

doxepin; systemic

2.2

9.8

103

493

J01MA12

ATC

levofloxacin; systemic

1.6

9.8

301

2045

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.3

9.7

144

KH1AD

NOMESCO Finland

CT of urinary organs

2.9

9.7

206

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

9.7

137

738

R2110

NOMESCO Finland

Giving the first information

2.0

9.7

118

598

N05BB01

ATC

hydroxyzine; systemic

2.0

9.7

116

585

Z50.1

ICD-10 Finland

Other physical therapy

2.2

9.7

461

SPAT1216

SPAT

Assessment of functional ability

1.6

9.7

258

1688

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.2

9.6

442

D10

ICPC

Vomiting

2.3

9.6

389

M22.4

ICD-10 Finland

Chondromalacia patellae

2.8

9.6

218

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

9.6

147

815

P76

ICPC

Depressive disorder

2.2

9.5

436

K30

ICD-10 Finland

Functional dyspepsia

1.8

9.5

165

953

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

9.5

156

885

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.1

9.5

169

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

9.5

158

902

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

7.2

9.5

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.3

9.5

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

4.8

9.5

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.2

9.5

153

A10BA02

ATC

metformin; oral

1.5

9.5

430

3179

P01

ICPC

Feeling anxious/nervous/tense

1.9

9.4

146

812

F32

ICD-10 Finland

Depressive episode

2.4

9.4

346

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

9.4

146

813

L03

ICPC

Low back symptom/complaint

1.5

9.4

363

2593

RS222

NOMESCO Finland

4.3

9.4

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.9

9.4

199

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

9.4

287

1945

34300

ICD-8 Finland

Cerebral spastic infantile paralysis, Hemiplegia spastica

+∞

9.4

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

9.4

502

3827

H46

ICD-10 Finland

Optic neuritis

5.6

9.4

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.5

9.3

291

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.1

9.3

166

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.6

9.3

248

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.9

9.3

145

809

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

9.3

158

909

S18

ICPC

Laceration/cut

1.4

9.3

627

4981

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.5

9.3

285

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

9.3

161

932

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.6

9.2

113

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

4.4

9.2

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.7

9.2

103

P99

ICPC

Psychological disorders other

2.9

9.2

183

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

9.2

169

994

A29

ICPC

General symptom/complaint other

1.7

9.1

179

1076

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

6.7

9.1

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

9.1

106

531

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

9.1

168

990

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

5.2

9.1

R03BA02

ATC

budesonide; inhalant

1.6

9.0

279

1894

A03

ICPC

Fever

1.6

9.0

238

1553

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

9.0

247

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

9.0

120

634

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.8

9.0

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

7.1

9.0

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

7.1

9.0

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

7.1

9.0

L01

ICPC

Neck symptom/complaint

1.7

9.0

202

1260

P06

ICPC

Sleep disturbance

1.8

9.0

146

825

XF402

NOMESCO Finland

ECG with work load test

1.7

9.0

174

1041

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

9.0

304

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.0

9.0

165

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.5

9.0

296

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

9.0

187

1145

79199

ICD-8 Finland

Headache

3.6

8.9

106

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.2

8.9

402

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

8.9

134

738

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

8.9

195

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.2

8.9

144

N05AF03

ATC

chlorprothixene; systemic

2.9

8.9

183

R05

ICPC

Cough

1.5

8.9

324

2286

F45.0

ICD-10 Finland

Somatization disorder

8.0

8.8

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

5.0

8.8

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

8.8

297

2057

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

5.2

8.8

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

3.2

8.8

140

R10.0

ICD-10 Finland

Acute abdomen

2.7

8.7

224

SPAT1284

SPAT

Extensive health certificate

2.8

8.7

203

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.3

8.6

125

F10.24

ICD-10 Finland

Alcohol depence active use

4.0

8.6

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

3.7

8.6

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.1

8.6

148

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

16.4

8.5

C10AA07

ATC

rosuvastatin; oral

1.5

8.5

339

2434

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.7

8.5

206

J02AC01

ATC

fluconazole; systemic

1.4

8.5

618

4954

WX890

NOMESCO Finland

Intesive care monitoring

5.0

8.5

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

8.5

181

1114

N17

ICPC

Vertigo/dizziness

1.7

8.5

168

1015

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

3.1

8.4

144

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.6

8.4

225

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.7

8.4

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

8.4

150

873

3001A

ICD-9 Finland

Neurotic disorders, Hysteria[KONVERSIOHÄIRIÖ]

90.4

8.4

C08DA01

ATC

verapamil; systemic

2.2

8.4

395

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

8.4

100

506

J01DB01

ATC

cefalexin; oral

1.4

8.4

1376

12486

K10.3

ICD-10 Finland

Alveolitis of jaws

2.3

8.4

321

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.2

8.4

134

G82.5

ICD-10 Finland

Tetraplegia, unspecified

+∞

8.3

34409

ICD-8 Finland

Other cerebral paralysis, Unspecified

+∞

8.3

L03AB07

ATC

interferon beta-1a; parenteral

6.2

8.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

8.3

355

ZXA10

NOMESCO Finland

Bilateral

1.5

8.3

293

2049

G54.9

ICD-10 Finland

Nerve root and plexus disorder, unspecified

10.8

8.3

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

8.3

135

767

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.1

8.3

474

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

9.5

8.3

F32.8

ICD-10 Finland

Other depressive episodes

4.4

8.2

N06AX12

ATC

bupropion; oral

2.1

8.2

466

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.2

8.2

125

Z72.0

ICD-10 Finland

Tobacco use

3.0

8.2

153

XA400

NOMESCO Finland

EEG

6.5

8.2

N06AX05

ATC

trazodone; oral

2.8

8.2

176

G04BD07

ATC

tolterodine; oral

2.1

8.1

470

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.3

8.1

115

N06AA06

ATC

trimipramine; systemic

2.8

8.1

177

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

8.1

133

754

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.7

8.1

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

8.1

114

614

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

8.1

361

2649

PA6BM

NOMESCO Finland

MRI examination of neck vasculature with 3 Tesla magnet

33.5

8.1

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.3

8.1

322

N06AG02

ATC

moclobemide; oral

2.2

8.1

355

N05AN01

ATC

lithium; oral

2.9

8.0

166

A10AA02

ATC

2.4

8.0

295

M01AB51

ATC

indometacin, combinations; oral, rectal

2.7

8.0

196

E66.9

ICD-10 Finland

Obesity, unspecified

2.6

8.0

214

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

7.9

113

612

F80.1

ICD-10 Finland

Expressive language disorder

4.9

7.9

H02AB04

ATC

methylprednisolone; systemic

1.6

7.9

233

1562

N02CC03

ATC

zolmitriptan; nasal, oral

2.1

7.9

413

2AB04

NOMESCO Finland

13.1

7.9

NA1BM

NOMESCO Finland

Cervical spine MRI examination with 3 Tesla magnet

13.1

7.9

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

7.9

116

634

T74.1

ICD-10 Finland

Physical abuse

3.3

7.9

113

M35.7

ICD-10 Finland

Hypermobility syndrome

3.9

7.9

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.7

7.8

186

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

4.3

7.8

J01CA08

ATC

pivmecillinam; oral

1.3

7.8

620

5026

M01AB55

ATC

diclofenac, combinations; oral

1.9

7.8

118

654

R06.4

ICD-10 Finland

Hyperventilation

3.3

7.8

114

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

7.8

121

676

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

7.8

146

867

C08DB01

ATC

diltiazem; oral

1.9

7.8

106

567

D07AA02

ATC

hydrocortisone; topical

1.6

7.7

211

1389

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

7.7

230

1546

S01.0

ICD-10 Finland

Open wound of scalp

1.9

7.7

115

632

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

7.7

121

680

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

7.7

119

665

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

7.7

192

1236

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

3.3

7.7

110

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

7.7

210

1385

H66.9

ICD-10 Finland

Otitis media, unspecified

2.0

7.6

440

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

7.6

259

1795

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.4

7.6

K92.1

ICD-10 Finland

Melaena

2.0

7.6

481

L11

ICPC

Wrist symptom/complaint

1.9

7.6

116

644

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

4.2

7.6

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

8.1

7.6

R21

ICPC

Throat symptom/complaint

1.5

7.6

275

1935

R03AC03

ATC

terbutaline; inhalant

1.6

7.6

218

1454

N03AX15

ATC

zonisamide; oral

11.9

7.6

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.7

7.6

185

WX730

NOMESCO Finland

Conventional respirator

3.2

7.5

117

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

10.1

7.5

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.3

7.5

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.9

7.5

156

N06AB05

ATC

paroxetine; oral

2.0

7.5

502

K02.9

ICD-10 Finland

Dental caries, unspecified

3.6

7.5

SPAT1210

SPAT

Application of cast or individual aid

2.3

7.5

308

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.3

7.5

107

R03AC13

ATC

formoterol; inhalant

2.0

7.4

439

N30

ICD-10 Finland

Cystitis

1.8

7.4

120

677

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

3.0

7.4

135

N05AD01

ATC

haloperidol; systemic

2.2

7.4

309

J01DA08

ATC

[U] cefaclor; oral

1.7

7.4

166

1038

A11

ICPC

Chest pain NOS

1.8

7.4

114

634

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

13.4

7.4

T90.5

ICD-10 Finland

Sequelae of intracranial injury

4.1

7.4

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

6.0

7.4

N05BA02

ATC

chlordiazepoxide; systemic

2.7

7.4

174

K04.0

ICD-10 Finland

Pulpitis

1.7

7.4

146

883

R03BB04

ATC

tiotropium bromide; inhalant

1.6

7.4

175

1113

R03AC12

ATC

salmeterol; inhalant

2.0

7.4

461

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

7.3

436

3366

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

7.3

477

3744

3449X

ICD-9 Finland

Other paralytic syndromes, Paralysis, unspecified

+∞

7.3

N88

ICPC

Epilepsy

6.8

7.3

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

9.4

7.3

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

7.3

239

1642

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

7.3

174

1108

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.4

7.3

257

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.1

7.3

126

N05AD03

ATC

melperone; systemic

3.1

7.3

126

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

7.2

183

1181

C09AA02

ATC

enalapril; systemic

1.4

7.2

329

2421

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.8

7.2

155

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

7.2

500

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.1

7.2

394

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

7.2

473

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

7.2

112

626

G20

ICD-10 Finland

Parkinson disease

2.3

7.2

261

L15

ICPC

Knee symptom/complaint

1.5

7.2

290

2087

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

4.4

7.1

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

20.1

7.1

R5599

NOMESCO Finland

Other rehabilitation service

2.6

7.1

198

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

6.6

7.1

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

7.1

274

R05

ICD-10 Finland

Cough

1.5

7.1

281

2010

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

2.9

7.1

144

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.0

7.1

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

12.1

7.1

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

6.0

7.1

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

6.0

7.1

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

3.0

7.1

123

U04

ICPC

Incontinence urine

2.1

7.1

342

S20.2

ICD-10 Finland

Contusion of thorax

2.1

7.0

391

S00.0

ICD-10 Finland

Superficial injury of scalp

2.9

7.0

145

WX882

NOMESCO Finland

High dependency care

2.5

7.0

200

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

10.1

7.0

UJD02

NOMESCO Finland

Gastroscopy

2.0

7.0

419

J01AA02

ATC

doxycycline; systemic

1.3

7.0

1317

11991

R5110

SPAT

2.7

7.0

176

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.0

7.0

124

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.5

7.0

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

3.1

7.0

113

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

6.9

789

6710

R1260

NOMESCO Finland

Evaluation of communicative skills

3.1

6.9

119

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.8

6.9

147

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

6.9

495

R39.1

ICD-10 Finland

Other difficulties with micturition

2.5

6.9

214

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.9

6.9

511

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

13.8

6.9

R41.0

ICD-10 Finland

Disorientation, unspecified

2.3

6.9

285

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.4

6.8

K04.08

ICD-10 Finland

Other specified pulpit

1.9

6.8

491

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.4

6.8

236

NGA20

NOMESCO Finland

Exploration of soft tissue knee or lower leg, open

11.0

6.8

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

9.3

6.8

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

9.3

6.8

N04BC05

ATC

pramipexole; oral

1.8

6.8

113

649

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

6.8

172

1112

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

2.0

6.8

449

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

6.8

120

702

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.3

6.8

248

RS230

NOMESCO Finland

5.3

6.8

G91.0

ICD-10 Finland

Communicating hydrocephalus

5.7

6.8

K02.1

ICD-10 Finland

Caries of dentine

1.3

6.7

844

7260

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.3

6.7

Y04.2

ICD-10 Finland

Assault by bodily force by friend

16.7

6.7

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

6.7

249

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

6.7

121

709

Z73.6

ICD-10 Finland

Limitation of activities due to disability

4.3

6.7

N02AC04

ATC

dextropropoxyphene; oral

2.0

6.7

400

G40.89

ICD-10 Finland

Other epilepsy

7.2

6.7

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.2

6.7

100

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

4.1

6.7

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.3

6.7

271

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

6.7

429

3352

R32

ICD-10 Finland

Unspecified urinary incontinence

2.5

6.7

194

D06

ICPC

Abdominal pain localized other

1.8

6.7

117

681

40199

ICD-8 Finland

Essential benign hypertension

2.6

6.7

176

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

6.4

6.6

M01AH02

ATC

rofecoxib; oral

1.5

6.6

209

1424

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.1

6.6

368

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.9

6.6

124

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

12.3

6.6

30041

ICD-8 Finland

Neuroses, Depressiva

3.9

6.6

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.8

6.6

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

10.1

6.5

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

6.9

6.5

X78

ICD-10 Finland

Intentional self-harm by sharp object

6.9

6.5

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

6.9

6.5

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.1

6.5

315

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.8

6.5

112

650

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

3.6

6.5

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

4.0

6.5

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.0

6.5

114

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

6.5

169

1103

Y07

ICD-10 Finland

Other maltreatment

6.2

6.5

J18

ICD-10 Finland

Pneumonia, organism unspecified

5.3

6.5

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

6.5

420

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

6.4

147

926

P74

ICPC

Anxiety disorder/anxiety state

2.3

6.4

230

R03DC03

ATC

montelukast; oral

1.5

6.4

231

1621

E66.8

ICD-10 Finland

Other obesity

2.0

6.4

380

N85

ICPC

Congenital anomaly neurological

70.1

6.4

JN4BD

NOMESCO Finland

Extensive body CT

1.6

6.4

159

1022

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

2.9

6.4

130

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

7.4

6.4

A03FA02

ATC

cisapride; oral, rectal

1.7

6.4

132

810

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.6

6.4

EBA30

NOMESCO Finland

Excision of root of tooth

2.0

6.4

400

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

2.3

6.4

256

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

4.9

6.4

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.6

6.4

162

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.3

6.3

225

G43

ICD-10 Finland

Migraine

2.1

6.3

299

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.9

6.3

503

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.8

6.3

132

RT150

NOMESCO Finland

8.2

6.3

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

6.3

336

2540

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

3.5

6.3

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.4

6.3

207

L01AX03

ATC

temozolomide; systemic

6.0

6.3

N05CD08

ATC

midazolam; nasal, systemic

2.4

6.3

199

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

11.1

6.3

N81

ICPC

Injury nervous system other

11.1

6.3

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.7

6.3

156

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

6.3

537

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

9.3

6.3

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

9.3

6.3

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.6

6.3

M75.5

ICD-10 Finland

Bursitis of shoulder

2.8

6.3

133

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.3

6.3

227

XKD00

NOMESCO Finland

Uroflowmetry

1.5

6.3

244

1741

G82.0

ICD-10 Finland

Flaccid paraplegia

+∞

6.3

G82.4

ICD-10 Finland

Spastic tetraplegia

+∞

6.3

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

6.2

559

A10AE04

ATC

insulin glargine; parenteral

1.6

6.2

137

855

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

3.4

6.2

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

3.4

6.2

G41.8

ICD-10 Finland

Other status epilepticus

26.8

6.2

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.2

6.2

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.3

6.2

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.2

6.2

287

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.8

6.2

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

6.3

6.2

E87.6

ICD-10 Finland

Hypokalaemia

2.4

6.2

214

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

6.1

300

L02

ICPC

Back symptom/complaint

1.7

6.1

134

832

WX290

NOMESCO Finland

Other blockade of nerve

1.3

6.1

625

5216

L04

ICPC

Chest symptom/complaint

1.9

6.1

445

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

7.7

6.1

3459X

ICD-9 Finland

Epilepsy, unspecified

7.7

6.1

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

7.7

6.1

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

6.1

446

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

3.5

6.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

6.1

103

592

G72.9

ICD-10 Finland

Myopathy, unspecified

4.7

6.1

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.8

6.1

130

I84

ICD-10 Finland

Hemorrhoids

2.4

6.1

205

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

3.9

6.1

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.1

6.1

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.2

6.0

250

Z72.2

ICD-10 Finland

Drug use

6.7

6.0

43300

ICD-8 Finland

Cerebral thrombosis, Wtih hypertension (benign)

10.0

6.0

A08

ICPC

Swelling

2.1

6.0

306

JAH01

NOMESCO Finland

Laparoscopy

2.0

6.0

345

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

3.5

6.0

6202X

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other and unspecified ovarian cyst

3.5

6.0

U05

ICPC

Urination problems other

2.0

6.0

333

R20.1

ICD-10 Finland

Hypoaesthesia of skin

5.2

6.0

G51.0

ICD-10 Finland

Bell palsy

2.4

6.0

191

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018677) aPTT in Platelet poor plasma by Coagulation assay

605

2342

3.23

117.31

3.6

2.0

29.7

29.8

0.17

584

2266

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

910

4580

2.75

107.35

3.2

2.1

156.9

221.6

u/l

1.87

878

4302

(3044290) Cell count panel - Cerebral spinal fluid

163

289

6.03

88.78

1.6

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

175

361

5.20

80.75

1.6

1.3

463.7

497.0

mg/l

0.59

164

338

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

160

322

5.30

75.86

1.6

1.5

300.0

695.5

e6/l

0.45

126

263

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

160

322

5.30

75.86

1.6

1.4

6.6

37.4

e6/l

0.98

120

253

(3033658) Prothrombin time (PT) actual/Normal

731

3896

2.35

69.60

6.1

3.8

91.2

89.6

0.87

720

3788

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

153

322

5.05

68.82

1.4

1.3

3.7

3.8

mmol/l

0.09

140

299

(3023410) Appearance of Cerebral spinal fluid

101

148

7.12

65.99

1.4

1.6

—

(3036489) Thrombin time

199

581

3.68

58.05

3.0

1.9

20.8

21.4

1.16

182

519

(3030467) Casts [#/volume] in Urine by Automated count

735

4289

2.10

52.92

4.0

3.2

0.4

0.5

e6/l

0.94

580

3272

(36304419) Bacteria [Presence] in Urine

722

4196

2.10

52.45

4.0

3.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

100

7.63

51.89

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

557

2953

2.21

51.06

5.2

3.8

139.8

360.5

ng/l

2.41

413

2292

(3032080) INR in Blood by Coagulation assay

965

6288

1.99

50.56

10.6

9.6

1.2

1.3

inr

1.11

249

1825

(3002582) Erythrocytes [#/volume] in Urine

780

4714

2.05

50.55

4.2

3.3

114.5

85.6

e6/l

0.16

625

3650

(3013826) Glucose [Moles/volume] in Serum or Plasma

1262

9095

1.98

48.56

6.8

4.7

6.5

6.7

mmol/l

2.13

1217

8506

(3023368) Bacteria identified in Blood by Culture

724

4326

2.03

47.87

5.1

4.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

478

2461

2.22

46.58

3.6

3.0

3.3

2.4

e6/l

1.01

265

1361

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

152

5.79

45.64

1.0

1.1

—

(3026782) Osmolality of Urine

563

3113

2.11

45.59

3.1

2.8

545.2

546.9

mosm/kgh2o

0.07

499

2637

(3016018) Differential panel - Cerebral spinal fluid

146

5.88

45.33

1.5

1.4

—

(3018095) Leukocytes [#/volume] in Urine

856

5504

1.94

45.17

5.1

3.8

56.3

107.8

e6/l

1.96

642

3924

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

597

3401

2.06

44.44

2.6

1.7

0.9

1.2

mg/l

3.71

459

2584

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

109

6.71

44.35

1.3

1.2

32.8

37.3

mg/l

0.49

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

130

6.11

43.85

1.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

319

1419

2.47

43.36

3.0

2.4

30.2

41.2

u/l

1.90

279

1208

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1010

6988

1.86

41.42

7.6

6.0

1.2

mmol/l

1.08

935

6314

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

482

2611

2.10

40.60

3.5

2.8

1.1

1.2

e6/l

0.26

266

1506

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

106

6.40

39.48

1.2

1.1

237.9

244.1

mg/l

0.13

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

136

5.60

38.59

2.1

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

960

6646

1.82

38.31

5.1

4.8

35.1

35.4

g/l

0.84

882

6181

(3014111) Lactate [Moles/volume] in Serum or Plasma

298

1359

2.39

38.06

8.0

7.2

1.3

1.4

mmol/l

0.50

285

1304

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1070

7711

1.80

36.83

7.9

6.6

1.2

mmol/l

0.50

922

6472

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

466

2591

2.03

36.07

2.0

1.8

—

(4027681)

6.53

35.48

1.4

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

451

2495

2.03

35.32

4.5

3.3

0.8

mmol/l

2.72

414

2331

(42870588) Differential panel, method unspecified - Blood

780

5231

1.78

33.32

6.8

5.8

—

(3018418) pH of Serum or Plasma

698

4537

1.81

33.08

4.2

3.9

7.4

0.19

125

855

(3026008) Bacteria identified in Urine by Culture

716

4697

1.80

32.86

4.0

3.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1091

8074

1.74

32.75

6.2

6.0

10.5

11.6

umol/l

2.06

1036

7630

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.85

32.74

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

548

3319

1.88

32.53

3.1

2.6

6.6

5.9

e6/l

0.51

491

2917

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

348

1805

2.11

32.18

1.9

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

738

4929

1.77

31.58

2.8

2.4

—

(3000991) Gas panel - Venous blood

277

1322

2.26

31.53

10.5

8.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1313

10299

1.74

31.36

6.6

4.5

654.8

1949.7

e6/l

0.89

156

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

6.84

30.19

1.3

1.9

—

(3001604) Monocytes [#/volume] in Blood

1041

7713

1.70

30.18

7.4

5.7

0.6

e9/l

0.01

907

6668

(3006315) Basophils [#/volume] in Blood

1041

7738

1.69

29.61

7.4

5.7

0.0

e9/l

0.13

904

6696

(4198724)

8.26

29.52

1.9

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

341

1810

2.06

29.46

1.9

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

294

1480

2.15

29.20

4.9

3.8

5.9

5.8

kpa

0.05

283

1425

(3013115) Eosinophils [#/volume] in Blood

1065

8015

1.67

28.48

7.8

5.9

0.2

e9/l

0.78

937

7043

(3002032) Base excess in Venous blood by calculation

290

1470

2.13

28.25

4.9

3.8

2.0

1.9

mmol/l

0.03

240

1148

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

186

782

2.51

28.07

5.2

4.2

24.2

24.0

mmol/l

0.57

174

712

(3019069) Monocytes/100 leukocytes in Blood

988

7312

1.67

28.03

7.8

6.1

8.3

8.6

2.19

934

6846

(3019198) Lymphocytes [#/volume] in Blood

1054

7932

1.66

28.02

7.6

5.7

2.0

1.9

e9/l

0.09

931

7001

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

112

359

3.24

28.00

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

112

359

3.24

28.00

1.4

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

10.85

27.80

1.2

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

204

906

2.39

27.31

1.3

57.5

42.2

au/ml

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

873

6297

1.66

27.07

2.3

2.0

90.8

94.5

pmol/l

1.58

476

3289

(3006504) Eosinophils/100 leukocytes in Blood

980

7281

1.65

27.06

7.5

5.8

2.6

2.8

3.08

921

6779

(3002030) Lymphocytes/100 leukocytes in Blood

1005

7520

1.65

26.94

7.7

5.9

27.5

27.8

0.40

945

7011

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

207

935

2.35

26.65

1.9

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

348

1927

1.97

26.49

8.3

6.9

104.7

104.3

mmol/l

0.82

343

1886

(3022096) Basophils/100 leukocytes in Blood

953

7070

1.64

26.17

7.6

5.9

0.6

0.7

1.18

893

6586

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

188

821

2.42

26.10

10.5

9.8

24.7

24.3

mmol/l

0.83

176

767

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

6.57

26.03

3.5

2.2

66.9

48.3

umol/l

2.23

(3018010) Neutrophils/100 leukocytes in Blood

988

7403

1.64

26.02

7.5

5.7

57.8

57.4

0.62

932

6927

(3003458) Phosphate [Moles/volume] in Serum or Plasma

367

2081

1.93

26.01

6.3

5.8

1.0

mmol/l

0.04

339

1923

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

322

1761

1.98

25.33

2.7

7.3

8.4

umol/l

0.45

279

1531

(3037467) Urinalysis macro (dipstick) panel - Urine

1325

10722

1.65

25.23

5.9

4.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.78

25.10

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

132

498

2.76

24.74

3.4

3.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

5.43

24.51

1.1

1.0

1.1

u/l

0.70

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

826

5987

1.63

24.40

5.1

3.6

106.0

52.7

ng/l

0.32

557

4073

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

120

437

2.85

24.03

2.4

2.3

179.3

180.1

0.03

114

418

(3013650) Neutrophils [#/volume] in Blood by Automated count

1145

9000

1.60

24.01

10.1

8.7

4.4

4.1

e9/l

2.47

996

7868

(40758558) Short blood count panel - Blood

592

3959

1.69

23.85

7.4

6.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

233

1157

2.14

23.76

1.8

1.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

318

1773

1.94

23.53

8.9

7.6

5.1

kpa

0.05

301

1682

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

135

529

2.66

23.49

2.2

2.3

241.6

471.6

ug/l

1.26

127

493

(3003396) Base excess in Arterial blood by calculation

316

1766

1.93

23.20

9.0

7.6

1.1

1.2

mmol/l

0.07

257

1358

(3027801) Oxygen [Partial pressure] in Arterial blood

317

1774

1.93

23.18

8.9

7.6

12.2

12.0

kpa

0.28

302

1685

(3024354) Oxygen [Partial pressure] in Venous blood

242

1234

2.09

23.00

4.4

3.1

4.9

4.6

kpa

1.01

232

1186

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

6.52

22.20

3.4

2.7

30.0

30.7

umol/l

0.11

(3019309) Folate [Moles/volume] in Red Blood Cells

460

2951

1.72

21.26

1.9

1.8

1050.1

1194.1

nmol/l

2.75

354

2216

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

556

3755

1.66

21.15

2.8

2.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

257

1382

1.98

21.02

6.7

7.7

9.4

10.1

mmol/l

0.77

239

1313

(3028707) Methadone [Presence] in Urine by Screen method

216

3.47

20.75

5.1

2.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

262

1430

1.95

20.50

2.3

2.1

378.3

369.1

nmol/l

0.29

237

1305

(4268621)

156

3.86

19.78

2.2

2.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

673

4839

1.58

19.48

3.0

2.5

56.7

57.3

u/l

0.12

622

4475

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

695

5045

1.57

19.24

3.7

3.2

29.5

32.9

u/l

2.62

651

4802

(3005719) IgG [Mass/volume] in Serum or Plasma

212

1101

2.03

19.07

2.4

2.7

10.0

10.6

g/l

1.30

186

1009

(3011397) Hemoglobin [Presence] in Urine by Test strip

515

3516

1.62

18.37

4.5

3.6

—

(3015736) pH of Urine

780

5871

1.52

18.04

4.5

3.4

—

5.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

336

2061

1.75

17.96

27.2

26.6

1.5

1.4

inr

0.69

271

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

436

2872

1.65

17.89

2.9

3.0

2.4

2.5

mmol/l

0.20

359

2521

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

117

490

2.47

17.75

8.4

2.0

92.9

90.5

0.45

109

457

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

299

1782

1.79

17.62

2.0

1.8

1.6

1.5

1.70

257

1555

(3015377) Calcium [Moles/volume] in Serum or Plasma

711

5269

1.53

17.57

3.3

2.3

2.4

mmol/l

1.27

600

4625

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1405

11991

1.53

17.43

9.0

7.3

81.6

79.1

u/l

0.98

1318

11237

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

109

449

2.51

17.14

5.8

2.3

3.8

3.6

g/l

0.43

102

420

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

239

3.08

17.03

1.3

1.2

1.3

3.8

u/ml

1.28

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

573

4095

1.55

16.52

2.6

2.2

3.1

3.0

mg/l

0.63

494

3463

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

236

3.03

16.14

1.3

1.2

3.0

4.4

u/ml

0.60

(3014007) Fractional oxyhemoglobin in Arterial blood

183

960

1.99

15.95

12.0

9.4

94.0

93.6

0.43

183

955

(3021589) Normoblasts [#/volume] in Blood

874

6858

1.47

15.91

12.3

9.3

0.0

e9/l

0.11

701

5601

(3021960) Folate [Moles/volume] in Serum or Plasma

513

3607

1.56

15.80

1.7

1.6

19.0

20.5

nmol/l

1.28

445

3097

(3042936) Bacteria identified in Isolate by Culture

350

2260

1.66

15.31

2.5

2.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1340

11467

1.47

15.24

5.1

4.0

13.5

12.4

mm/h

1.64

1246

10583

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

5.32

15.14

6.5

3.6

133.8

130.6

umol/l

0.03

(3037522) Nuclear Ab [Titer] in Serum

319

2032

1.67

14.66

1.5

1.3

471.7

505.1

titre

0.11

422

(3020630) Protein [Mass/volume] in Serum or Plasma

218

1249

1.83

14.54

1.7

2.6

65.7

66.7

g/l

0.94

187

1136

(3007853) Bacteria identified in Skin by Aerobe culture

290

1814

1.69

14.25

2.2

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

6.06

13.86

1.0

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

810

6415

1.43

13.34

2.5

2.2

74.8

76.9

nmol/l

1.15

735

5745

(3035350) Ketones [Presence] in Urine by Test strip

932

7572

1.42

13.28

5.0

3.6

0.0

estimate

0.00

176

1422

(3009466) Valproate [Moles/volume] in Serum or Plasma

241

2.79

13.23

5.2

5.6

356.4

358.7

umol/l

0.04

214

(3022948) Iron [Moles/volume] in Serum or Plasma

366

2470

1.58

13.22

2.8

2.5

11.6

13.0

umol/l

2.55

340

2276

(3024928) Oxygen saturation in Venous blood

335

2.51

13.17

2.4

3.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

320

2099

1.62

13.01

3.0

2.6

20.5

22.9

1.93

279

1810

(3002173) Hemoglobin [Mass/volume] in Arterial blood

236

1430

1.73

12.98

10.9

8.6

123.9

121.1

g/l

1.35

229

1376

(3051651) Icteric interference index of Serum or Plasma

100

3.85

12.90

2.9

3.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

930

7582

1.41

12.84

6.9

4.9

0.0

estimate

0.50

178

1448

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

340

2.47

12.77

2.5

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.55

12.70

1.3

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

342

2.45

12.61

2.5

3.1

31.7

35.4

umol/l

1.03

288

(3016502) Oxygen saturation in Arterial blood

252

1575

1.68

12.35

10.7

8.1

96.0

95.4

0.92

245

1513

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

4.12

12.31

13.8

12.5

0.6

0.7

mmol/l

1.01

(3009261) Glucose [Presence] in Urine by Test strip

935

7668

1.40

12.29

5.1

3.6

0.0

estimate

0.34

175

1395

(3004789) Transferrin [Mass/volume] in Serum or Plasma

337

2272

1.58

12.16

2.8

2.5

2.3

g/l

0.10

304

2096

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

105

3.67

12.05

1.0

1.1

0.1

4.0

nmol/l

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

587

4450

1.44

11.99

3.4

3.0

1301.0

1725.8

ng/l

1.58

503

3784

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

176

1003

1.82

11.91

4.9

3.9

1.7

mmol/l

0.04

133

734

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

4.86

11.90

1.2

—

(3009343) pH of Capillary blood

181

1043

1.80

11.81

4.9

3.9

7.4

0.39

117

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

147

793

1.92

11.81

13.6

11.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

100

469

2.19

11.75

1.3

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

182

1054

1.80

11.68

5.0

3.9

5.2

5.1

kpa

0.25

169

980

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.55

11.64

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

164

3.03

11.52

2.9

3.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.41

11.35

1.0

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

231

1444

1.67

11.29

2.6

2.3

0.2

g/l

1.38

212

1343

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

215

1321

1.70

11.21

2.3

2.4

6.4

6.8

ug/l

0.13

179

1154

(40768797) Stomach Pathology biopsy report

313

2123

1.56

10.93

1.3

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

105

521

2.07

10.70

10.0

2.6

0.3

0.4

u/ml

0.34

292

(3001122) Ferritin [Mass/volume] in Serum or Plasma

845

6924

1.37

10.68

3.4

2.8

117.5

126.0

ug/l

0.48

777

6399

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

300

2.41

10.66

1.7

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

880

7267

1.36

10.55

4.7

4.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

5.45

10.40

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

7.82

10.14

1.0

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

161

938

1.78

10.13

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

5.30

10.11

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

3.98

10.04

3.3

15.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

258

1707

1.58

10.00

3.6

4.1

235.2

243.6

u/l

0.53

243

1615

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

225

2.58

9.90

1.1

122.7

117.9

0.55

208

(3027945) Reticulocytes/100 erythrocytes in Blood

267

1785

1.57

9.90

2.6

2.7

1.8

0.25

232

1593

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

7.41

9.70

1.0

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

130

723

1.85

9.54

2.8

2.7

1.6

1.2

2.96

130

718

(1001926) Buprenorphine [Presence] in Urine by Screen method

395

2.15

9.46

4.9

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

442

2.08

9.46

1.5

282.3

288.2

ug/g

0.10

256

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

3.40

9.45

1.5

2.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

376

2.17

9.41

1.5

1.3

—

10.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

474

2.03

9.21

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

461

2.04

9.17

1.6

2.2

38.0

37.7

g/l

0.16

398

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

414

2.10

9.14

1.6

2.3

0.0

g/l

0.00

380

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.96

9.12

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

443

2.05

9.04

1.6

2.3

0.1

0.0

g/l

0.37

405

(4306422)

236

2.45

8.99

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

359

2605

1.46

8.95

1.4

1.3

30.2

32.3

iu/ml

0.07

828

(3007164) IgA [Mass/volume] in Serum or Plasma

399

2954

1.43

8.94

1.6

1.4

2.2

2.4

g/l

1.28

229

1784

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

418

2.08

8.92

1.6

2.3

0.0

g/l

0.00

381

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.35

8.87

1.3

1.1

—

(3034426) Prothrombin time (PT)

4.50

8.83

1.1

1.3

—

(3011288) Drugs identified in Urine by Screen method

341

2.18

8.74

2.8

2.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

102

540

1.93

8.72

1.5

2.3

10.1

10.5

g/l

0.40

461

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

492

1.97

8.65

1.6

2.4

0.3

1.1

g/l

2.83

430

(3016879) Cocaine [Presence] in Urine

479

1.99

8.61

4.5

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

188

2.59

8.51

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

446

3405

1.39

8.33

1.3

2.9

1.6

u/ml

0.62

903

(4010399)

169

1058

1.65

8.21

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

241

2.36

8.15

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.03

8.14

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

165

1029

1.65

8.13

1.5

2.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

3.33

8.07

1.2

1.6

4.7

6.5

u/l

1.18

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

393

2.05

8.06

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

513

1.91

8.00

4.5

1.7

—

(3028300) Cannabinoids [Presence] in Urine

520

1.89

7.69

4.5

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

104

579

1.84

7.65

1.5

2.2

7.0

7.3

g/l

1.03

447

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

152

944

1.66

7.62

3.4

3.3

4.3

4.5

pmol/l

2.71

137

832

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

6.70

7.60

1.1

1.3

—

(3027008) Opiates [Presence] in Urine

518

1.87

7.47

4.4

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

195

1294

1.56

7.44

2.6

2.7

70.9

70.8

e9/l

0.01

136

974

(3027944) Amphetamines [Presence] in Urine

512

1.87

7.42

4.7

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

103

578

1.82

7.40

1.5

2.2

3.9

3.7

g/l

0.32

426

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

103

579

1.82

7.36

1.5

2.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

509

4043

1.34

7.29

2.7

2.6

3203.3

5939.5

umol/l

1.02

421

3495

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

232

1606

1.50

7.29

4.5

3.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.08

7.16

1.0

1.2

—

(21494755) Public health laboratory ask at order entry panel

1409

0.53

7.12

1.2

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

549

1.82

7.09

1.6

2.3

2.9

3.1

g/l

1.35

435

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

177

1170

1.56

6.88

3.5

4.0

85.1

89.0

ng/l

0.25

146

1028

(3048689) Calprotectin [Mass/mass] in Stool

258

1845

1.45

6.88

2.2

2.4

116.1

124.6

ug/g

0.22

190

1457

(3017143) Hepatitis C virus Ab [Presence] in Serum

239

1684

1.47

6.87

1.5

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

301

2.09

6.80

2.6

16.6

16.2

0.27

163

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

113

669

1.73

6.79

5.5

4.2

24.8

24.7

mmol/l

0.05

104

626

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1144

10187

1.27

6.70

4.3

3.1

54.9

48.9

u/l

1.28

1065

9510

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.17

6.70

1.1

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

139

875

1.63

6.64

2.0

1.8

1.3

1.5

g/l

0.40

129

806

(44816559) Phosphatidylethanol [Mass/volume] in Blood

278

2.12

6.59

1.4

1.3

—

(1761868) Lipid panel - Serum or Plasma

440

5483

0.75

6.58

3.1

2.8

—

(3022313) Gas panel - Capillary blood

126

776

1.66

6.56

5.4

4.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

454

1.86

6.50

2.4

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

108

640

1.72

6.48

2.0

1.9

2.8

1.6

ug/l

0.45

561

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1315

11937

1.27

6.45

4.7

4.0

14.6

14.7

pmol/l

1.47

1202

10871

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

331

2507

1.38

6.36

1.3

1.2

4.6

11.1

u/ml

2.15

109

989

(3023511) Choriogonadotropin [Units/volume] in Urine

269

2.11

6.34

1.6

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

482

1.82

6.25

2.6

2.1

6670.0

3928.8

u/l

0.31

200

(3035637) Corticotropin [Mass/volume] in Plasma

168

2.41

6.21

1.7

1.6

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.14

6.16

2.3

2.6

993.5

1392.4

u/ml

0.33

(36660697) Celiac disease serology panel - Serum

176

1196

1.51

6.05

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

429

1.85

6.03

1.3

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

299

2.00

5.82

1.5

1.2

38.9

50.0

u/ml

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

524

1.75

5.78

1.6

400.6

303.5

mu/l

0.96

481

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

120

2.61

5.72

1.2

1.1

170.0

149.5

titre

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

227

2.14

5.68

1.5

1.6

0.7

0.8

g/l

0.46

169

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.55

5.60

1.1

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

403

1.84

5.60

1.9

1.4

11.4

10.7

u/l

0.17

320

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.50

5.51

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.97

5.41

1.7

1.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

112

2.61

5.39

2.2

1.5

1.7

1.3

promille

0.78

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

184

1293

1.46

5.38

3.2

2.9

228.0

220.2

ng/l

0.08

158

1175

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.58

5.32

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.58

5.32

1.1

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

2.93

5.30

1.2

1.3

146.0

144.1

nmol/l

0.05

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

471

1.75

5.25

1.5

1.6

0.1

14.0

iu/ml

0.49

(3021788) Differential panel - Synovial fluid

276

1.98

5.23

1.7

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

406

1.80

5.18

1.6

1.3

—

(3011985) Renin [Units/volume] in Plasma

172

2.23

5.04

1.4

112.5

44.9

mu/l

0.48

154

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.28

5.04

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

464

1.73

4.97

1.3

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

489

1.70

4.89

1.6

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

414

1.77

4.88

5.0

3.3

24.8

mmol/l

0.00

366

(3023323) Follitropin [Units/volume] in Serum or Plasma

113

732

1.57

4.86

1.6

1.4

22.0

28.8

iu/l

1.52

618

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.72

4.84

2.3

2.2

—

(3000494) Fungus identified in Specimen by Culture

239

1797

1.37

4.79

1.6

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

470

1.71

4.76

1.5

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.16

4.62

1.2

1.1

106.8

92.3

1.39

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

207

1534

1.39

4.53

2.7

4.0

27.0

18.6

ug/l

0.21

152

1256

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

10.03

4.52

1.0

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

278

2160

1.33

4.50

1.5

1.6

—

(3008295) Osmolality of Serum or Plasma

181

2.12

4.48

1.6

1.3

281.8

279.0

mosm/kgh2o

0.34

133

(3012501) Base excess in Blood by calculation

343

1.80

4.48

5.0

4.6

2.3

2.6

mmol/l

0.55

233

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.28

4.46

1.1

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

464

1.68

4.45

1.3

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

100

645

1.58

4.41

1.5

2.0

41.5

39.3

u/l

0.49

575

(3003181) Sodium [Moles/volume] in Urine

273

1.89

4.37

1.7

1.3

68.0

63.5

mmol/l

0.27

217

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

368

1.76

4.37

1.5

1.2

3.4

10.0

u/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

151

1066

1.45

4.35

1.1

1.2

206.9

150.2

iu/ml

0.53

420

(46235355) HIV 1 and 2 tests - Meaningful Use set

325

2593

1.30

4.34

1.7

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

332

1.80

4.33

2.1

2.2

130.7

129.8

g/l

0.10

249

(3019060) Gas panel - Arterial blood

147

1035

1.45

4.30

5.6

5.0

—

(3029937) Albumin [Presence] in Urine by Test strip

486

4087

1.25

4.21

6.0

3.9

0.0

estimate

1.08

169

1385

(1616796) Gas panel - Central venous blood

351

1.76

4.17

4.1

3.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

106

703

1.53

4.16

1.8

1.9

1.5

g/l

0.15

616

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

6.45

3.98

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.49

3.96

1.4

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

853

0.56

3.91

1.6

1.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

100

2.42

3.89

2.1

13.5

14.6

0.13

(3024139) IgG subclass 3 [Mass/volume] in Serum

132

2.21

3.86

1.3

0.3

0.4

g/l

0.54

(3027135) IgG subclass 1 [Mass/volume] in Serum

132

2.21

3.86

1.3

6.9

7.0

g/l

0.04

(3028192) IgG subclass 2 [Mass/volume] in Serum

132

2.21

3.86

1.3

2.7

2.9

g/l

0.13

(3005322) IgE [Units/volume] in Serum or Plasma

138

983

1.43

3.82

1.2

130.6

194.8

u/ml

0.90

127

906

(3021879) Hepatitis B virus core Ab [Presence] in Serum

151

1094

1.41

3.81

1.4

—

(3011648) Oxygen content in Venous blood

120

2.27

3.80

2.7

3.5

10.7

11.0

0.12

120

(3014148) Varicella zoster virus Ab [Titer] in Serum

174

2.03

3.74

1.2

—

(3020891) Body temperature

623

1.53

3.73

5.5

4.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

591

1.55

3.72

2.3

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

238

1.87

3.70

1.0

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

148

2.11

3.69

1.2

52.5

57.6

u/l

0.18

106

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

649

1.52

3.69

2.3

1.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

365

1.69

3.67

1.6

1.7

8936.4

13105.4

e6/l

0.66

274

(40768443) Skin Pathology biopsy report

650

1.52

3.66

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

5.64

3.65

3.0

2.0

—

(4062490)

136

2.15

3.61

1.3

—

(3010421) pH of Blood

421

1.64

3.60

4.7

4.2

7.4

0.10

338

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

631

1.51

3.53

1.0

1.1

—

0.9

—

(3028717) Thiamine [Mass/volume] in Blood

6.17

3.50

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1366

0.67

3.50

1.8

1.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

165

2.02

3.50

8.6

7.6

6.7

7.3

mmol/l

0.76

145

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

204

1574

1.33

3.48

2.1

2.0

—

(3011412) CD3 cells [#/volume] in Blood

132

2.14

3.45

2.0

2.2

1.5

1.1

e9/l

0.99

(3009508) Creatinine [Moles/volume] in Urine

535

4629

1.21

3.45

3.7

3.1

7.6

7.5

mmol/l

0.06

438

3897

(3019150) Specific gravity of Urine by Refractometry

396

3326

1.23

3.42

5.7

4.0

1.0

kg/l

0.02

470

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

373

1.65

3.41

1.2

1.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

100

686

1.48

3.40

5.4

3.7

51.3

48.0

0.71

100

676

(3044941) Cell count panel - Synovial fluid

238

1.82

3.40

1.5

—

(3021901) Oxygen saturation in Capillary blood

290

1.74

3.38

4.0

2.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

185

1415

1.34

3.36

2.0

1.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.72

3.35

1.6

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1636

15627

1.22

3.34

25.8

14.3

23.0

24.2

mg/l

0.86

1441

12390

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

519

1.54

3.29

2.8

—

(3047181) Lactate [Moles/volume] in Blood

471

1.57

3.29

6.9

7.0

1.3

mmol/l

0.05

405

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.59

3.26

1.0

1.7

—

(40768804) Tissue Pathology biopsy report

700

6241

1.18

3.20

2.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.58

3.19

1.6

3.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

420

1.59

3.17

1.5

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

1674

17352

0.82

3.16

35.4

20.9

132.5

134.5

g/l

6.55

1653

17058

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

2.37

3.15

1.3

1.2

26.8

17.4

u/l

0.53

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

172

1.93

3.14

1.9

1.4

—

(3026361) Erythrocytes [#/volume] in Blood

1674

17346

0.82

3.10

35.1

20.8

4.4

4.5

e12/l

3.09

1637

16832

(3016650) Hepatitis A virus Ab [Presence] in Serum

238

1.78

3.10

1.1

—

(3035941) MCH [Entitic mass]

1674

17345

0.82

3.09

34.9

20.7

30.2

30.3

0.71

1653

17046

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.81

3.08

1.1

—

(3024731) MCV [Entitic volume]

1674

17343

0.82

3.08

35.0

20.8

91.0

0.01

1653

17049

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.34

3.08

1.3

1.2

118.4

79.7

u/l

0.94

(3010813) Leukocytes [#/volume] in Blood

1675

17351

0.82

3.06

35.1

20.9

7.1

6.8

e9/l

3.73

1638

16832

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.23

3.06

1.6

2.3

578.3

555.5

e6/l

0.07

(3000060) B lymphocytes [#/volume] in Blood

3.25

3.05

2.1

2.2

203.3

204.3

e6/l

—

(1002224) Polysomnography panel

627

1.47

3.05

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1432

15034

0.85

3.02

4.9

4.2

1.4

1.5

mmol/l

9.18

1314

13826

(3007461) Platelets [#/volume] in Blood

1674

17336

0.82

3.01

35.1

20.8

256.6

251.3

e9/l

2.49

1638

16864

(3013512) EKG study

505

4401

1.19

2.97

5.0

3.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.22

2.90

1.7

2.3

0.4

0.2

e9/l

0.44

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1446

15144

0.85

2.84

5.0

4.3

4.5

4.7

mmol/l

9.58

1332

14032

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.35

2.82

1.1

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

108

784

1.40

2.76

2.5

2.4

—

(4094501)

379

1.57

2.76

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

241

1.71

2.71

1.2

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

189

1.81

2.71

1.4

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

182

1.83

2.69

1.9

1.6

40.2

60.8

1.62

116

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.22

2.67

1.3

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

127

953

1.35

2.67

8.8

7.1

24.5

mmol/l

0.03

118

889

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1479

15438

0.85

2.67

5.5

4.7

2.6

2.8

mmol/l

7.74

1357

14200

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

161

1.88

2.66

1.3

1.4

291.0

307.4

pmol/l

0.15

122

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

564

1.45

2.62

1.7

1.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

458

1.50

2.59

2.2

1.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

192

1.78

2.58

1.4

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

130

985

1.34

2.57

1.2

—

(3044889) 12 lead EKG panel

1153

10804

1.15

2.57

4.3

3.7

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

4.01

2.56

3.9

1.5

—

mmol/l

—

(3014271) Vancomycin [Susceptibility]

2.14

2.54

3.0

2.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

515

4556

1.17

2.51

4.1

3.9

10.0

9.0

mg/mmol

0.18

331

2911

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

159

1245

1.30

2.50

4.8

3.7

1.2

mmol/l

0.47

146

1069

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

650

5861

1.16

2.47

5.8

3.8

—

(4024509)

130

1.93

2.45

1.4

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1489

14237

1.16

2.42

5.9

4.7

2.6

2.1

mu/l

0.25

1375

13026

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

914

0.68

2.40

1.6

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

182

1.77

2.40

1.2

1.3

—

nmol/l

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

190

1.75

2.37

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

190

1.75

2.37

1.4

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.65

2.36

3.5

2.7

0.8

0.7

u/field

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

236

1.66

2.36

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.51

2.36

1.5

2.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

191

1.74

2.34

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

191

1.74

2.34

1.4

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

147

1.85

2.33

3.4

4.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

184

1.75

2.32

1.4

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

269

1.61

2.29

3.4

3.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

450

3969

1.17

2.26

1.7

1.6

1.5

1.4

mmol/l

1.03

386

3353

(40759836) Histone Ab [Presence] in Serum by Immunoblot

106

1.99

2.25

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

106

1.99

2.25

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

106

1.99

2.25

1.4

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

258

0.42

2.24

1.4

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

2.05

2.21

1.7

1.6

6.5

8.7

u/l

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

107

1.97

2.20

1.5

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

107

1.97

2.20

1.5

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

107

1.97

2.20

1.5

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

158

1.78

2.17

1.7

3.3

61.8

55.3

0.75

110

(3019550) Sodium [Moles/volume] in Serum or Plasma

1656

16005

1.17

2.17

28.2

16.3

139.3

139.6

mmol/l

4.45

1628

15554

(3025941) Bacteria identified in Stool by Culture

116

889

1.32

2.17

1.4

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

242

1.62

2.16

1.4

1.1

367777.2

2266.3

iu/ml

—

(3000492) Spirometry study

181

1470

1.25

2.16

1.6

1.4

—

(3022145) Colonoscopy Study observation

205

1689

1.24

2.15

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

1362

12988

1.14

2.15

29.4

17.2

13.9

13.7

2.64

1340

12679

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

251

1.60

2.13

1.2

1.5

—

(3017732) Neutrophils [#/volume] in Blood

136

1069

1.29

2.12

3.7

2.9

4.3

4.1

e9/l

0.51

859

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.91

2.07

1.4

2.4

21.4

18.3

umol/l

—

(3012516) Albumin [Mass/volume] in Urine

484

4321

1.16

2.07

3.4

3.2

53.6

297.7

mg/l

4.24

326

2771

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

101

765

1.34

2.06

1.1

1.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

383

3361

1.17

2.05

1.9

1.7

444.1

25206889.8

pmol/l

2.62

331

2785

(3026389) Candida sp identified in Specimen by Organism specific culture

184

1.69

2.04

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.01

2.04

1.2

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1658

16049

1.16

2.03

28.2

16.5

3.9

4.0

mmol/l

6.19

1626

15568

(3035320) C reactive protein [Mass/volume] in Body fluid

111

1.90

2.01

4.0

2.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

155

1.75

2.00

1.3

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.15

1.98

1.1

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

305

2636

1.18

1.96

1.7

1.5

—

(40761536) Microorganisms panel - Urine sediment

165

1343

1.25

1.95

5.6

3.8

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.55

1.94

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.55

1.94

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.01

1.90

1.2

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.65

1.86

4.8

2.5

1.2

mmol/l

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

174

1.68

1.86

2.6

4.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

561

1.37

1.85

2.2

3.3

1554.2

7129.4

u/ml

0.56

478

(3026480) Teichoate Ab [Titer] in Serum

4.17

1.82

1.2

—

(3001556) Androgen free Index in Serum or Plasma

4.17

1.82

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

4.17

1.82

12.0

1.9

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.17

1.82

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

298

0.53

1.76

1.0

1.2

—

(3049717) Cytology report of Urine Cyto stain

601

1.34

1.76

2.0

2.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.34

1.74

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

194

1.61

1.71

1.2

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

194

1.61

1.71

1.2

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

148

1.70

2.5

2.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.92

1.70

1.1

1.0

259.3

300.7

ng/l

0.58

(3004451) EKG impression Narrative

2.01

1.69

1.6

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.96

1.69

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.96

1.69

1.1

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

187

1.61

1.69

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.16

1.66

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.90

1.65

1.1

1.0

27.8

47.1

ng/l

2.02

(3019225) pH of Specimen

181

1521

1.21

1.62

4.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

278

1.48

1.62

1.3

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

246

1.51

1.60

2.4

3.6

0.9

1.4

0.43

198

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1402

14512

0.90

1.58

4.4

3.8

1.4

1.3

mmol/l

5.63

1273

13282

(3020491) Glucose [Moles/volume] in Blood

114

1.76

1.56

2.4

1.7

7.7

6.8

mmol/l

0.49

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

107

1.78

1.54

1.7

2.1

999.9

689.7

e6/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1039

9859

1.11

1.54

3.6

3.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.98

1.54

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.98

1.54

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

169

1.61

1.52

1.3

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

153

1274

1.22

1.51

4.1

4.0

0.8

0.9

0.22

371

(3034860) Kappa light chains.free [Mass/volume] in Serum

460

1.36

1.51

1.8

3.4

45.3

65.5

mg/l

0.72

375

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.86

1.50

1.0

1.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

461

1.36

1.50

1.8

3.4

38.5

43.0

mg/l

0.21

377

(3017446) Testosterone [Moles/volume] in Serum or Plasma

126

1030

1.24

1.49

2.4

2.2

11.7

12.2

nmol/l

0.25

109

904

(4035726)

156

1304

1.21

1.49

1.5

1.4

—

(3022621) pH of Urine by Test strip

126

1031

1.24

1.48

3.4

3.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.81

1.47

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.85

1.45

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.85

1.45

1.4

—

(40761535) Cells panel - Urine sediment

154

1290

1.21

1.45

4.3

3.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

140

1162

1.22

1.44

4.0

3.9

0.4

0.6

0.92

273

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

228

1.50

1.44

2.1

1.4

25.3

u/l

0.00

184

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

106

854

1.25

1.43

2.0

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

212

1.52

1.43

1.3

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

449

1.35

1.41

9.5

4.0

1.6

mg/l

0.08

417

(3024869) Neuronal Ab [Presence] in Serum

2.42

1.39

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

706

1.27

1.38

1.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

231

1.48

1.36

1.4

0.2

0.4

nmol/l

2.00

180

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

135

1.64

1.35

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

457

4180

1.12

1.34

5.0

3.3

—

(3028433) Virus identified in Specimen by Culture

2.13

1.33

1.3

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

333

1.39

1.33

1.3

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

621

1.28

1.32

7.6

5.8

2.0

1.6

1.67

576

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

121

1.66

1.30

1.3

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

106

1.70

1.29

1.6

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.36

1.29

1.1

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

161

1.56

1.28

2.3

6.2

6.3

umol/l

0.01

113

(3042631) Mycobacterium sp identified in Specimen

210

1.48

1.27

2.4

2.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

100

815

1.24

1.25

1.4

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

445

4835

0.90

1.23

4.5

5.0

3.4

4.1

ug/l

0.19

394

4290

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

139

1.59

1.23

1.1

1.2

—

(3006270) Folate [Moles/volume] in Blood

139

1.59

1.23

1.1

1.2

339.2

380.7

nmol/l

0.41

125

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.63

1.21

2.0

1.5

59.8

47.5

umol/l

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

348

1.36

1.21

1.4

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

140

1.58

1.20

1.9

1.5

39.6

29.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

156

1.54

1.20

1.1

—

(3025159) Blasts/100 leukocytes in Blood

134

1132

1.20

1.19

4.3

4.1

0.1

0.6

0.66

289

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

1.88

1.18

1.3

72.0

60.7

0.60

(3007930) Methemoglobin/Hemoglobin.total in Blood

615

1.26

1.17

7.7

5.8

0.9

0.13

572

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

223

1.44

1.16

1.2

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

142

1209

1.19

1.16

4.3

4.0

0.2

0.1

0.25

343

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

1.15

0.0

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.90

1.12

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

135

1.56

1.11

1.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.96

1.11

2.5

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

375

3431

1.11

1.10

5.2

4.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

398

1.31

1.10

1.7

1.9

2.8

4.6

iu/l

1.75

133

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.82

1.09

2.1

4.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1490

14509

1.09

1.08

21.6

13.1

84.5

80.6

ml/min/173m2

8.84

1304

11954

(4133840)

2.19

1.08

1.6

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

261

1.39

1.07

1.3

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

354

3864

0.90

1.07

3.9

4.3

21.1

21.5

0.18

153

1895

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

105

1.62

1.06

1.6

1.3

13.4

14.3

u/l

0.17

(40760888) Immunoglobulin light chains.free panel - Serum

340

1.33

1.05

1.7

3.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.80

1.04

1.1

118.2

223.2

iu/ml

1.24

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.67

1.04

1.2

1.1

1.0

1.1

ratio

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

252

0.63

1.03

1.8

1.7

—

(3023419) Bacteria identified in Sputum by Culture

204

1.43

1.03

2.7

2.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.69

1.01

1.6

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.00

1.00

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

361

1.31

0.99

1.4

1.6

—

(3019977) pH of Arterial blood

1.71

0.99

1.6

3.4

7.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.81

0.98

1.0

1.1

2370.4

1738.2

miu/ml

0.66

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.63

0.97

2.3

2.2

131.7

255.2

ug/min

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

668

1.22

0.96

1.9

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

210

1875

1.13

0.95

9.2

7.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

259

1.36

0.95

1.5

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

141

1.49

0.94

1.4

1.7

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

1.77

0.94

1.2

1.1

13.1

28.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

135

1.49

0.89

2.3

4.8

2.1

u/field

0.54

(3029075) Extractable nuclear Ab panel - Serum

1.91

0.88

1.4

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

119

1.52

0.88

1.1

1.2

0.1

0.6

u/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.86

0.87

1.4

10.6

9.1

ug/l

—

(3052592) Norovirus Ag [Presence] in Stool

2.00

0.87

1.5

—

(4015189)

1.82

0.86

3.6

2.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

170

1.42

0.85

1.4

1.3

14893.9

95748.7

e6/l

1.24

101

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.67

0.85

3.4

2.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.94

0.84

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

261

0.69

0.82

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.74

0.82

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

320

1.29

0.80

1.6

2.0

0.9

nmol/l

0.23

266

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1462

14928

0.93

0.80

5.1

4.4

6.0

5.9

mmol/l

1.87

1314

13561

(3005033) Fetal Nuchal fold Thickness US

259

0.69

0.80

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.73

0.79

3.6

2.4

—

(3037756) Immunofixation for Serum or Plasma

321

1.28

0.79

1.4

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

270

0.70

0.79

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.82

0.79

1.7

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

190

1.37

0.79

1.2

1.4

7.2

7.4

mmol/l

0.10

135

(40768793) Breast Pathology biopsy report

360

0.75

0.77

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

115

1.48

0.76

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.77

0.76

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.54

0.75

1.4

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.54

0.75

1.4

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.09

0.74

1.6

1.3

—

(40758292) HTLV I+II Ab panel - Serum

2.09

0.74

1.2

1.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

1.67

0.74

1.3

1.7

2.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.84

0.73

3.1

1.9

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.00

0.72

1.6

1.0

30.0

142.8

ng/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

356

0.76

0.72

5.5

3.6

29.9

26.8

mg/l

0.13

230

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.61

0.72

1.1

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

276

0.72

1.7

1.5

—

(3024263) Appearance of Synovial fluid

1.55

0.71

1.2

1.7

—

(3045424) Erythrocytes [Presence] in Urine

255

1.30

0.71

1.4

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.58

0.71

1.5

1.4

83.2

392.5

pmol/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.92

0.70

1.0

1.1

—

(3008898) HLA-B27 [Presence]

537

1.20

0.69

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

169

1.36

0.69

1.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

519

0.81

0.69

1.6

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.85

0.68

1.6

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

540

0.81

0.68

1.6

1.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

329

1.25

0.68

1.5

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

188

1.33

0.66

1.5

1.3

1792.9

1573.6

e6/l

0.14

131

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.79

0.66

5.2

6.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

241

1.29

0.66

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.54

0.65

2.7

2.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

590

0.83

0.64

1.4

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.60

0.0

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

114

0.61

0.58

1.4

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.56

1.3

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.67

0.56

1.2

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

526

0.83

0.55

1.7

1.5

—

(40757373) Influenza virus identified in Isolate

1.62

0.55

1.5

1.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.62

0.55

5.2

6.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

251

0.75

0.55

4.7

3.9

26.4

31.9

u/ml

0.20

242

(3036071) Salmonella sp Ab [Titer] in Serum

1.48

0.53

1.1

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

1.40

0.51

1.2

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.50

0.51

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

144

1.32

0.50

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

252

1.23

0.49

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.43

0.49

1.3

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.43

0.49

1.2

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

1.56

0.49

2.0

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

178

0.73

0.48

2.9

2.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.52

0.48

1.0

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.49

0.47

1.4

2.2

—

(3000330) Specific gravity of Urine by Test strip

796

1.12

0.47

4.3

3.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

309

1.20

0.47

2.7

3.5

4.0

4.3

e9/l

0.18

309

(3044007) Cell count panel - Peritoneal fluid

1.46

0.46

1.3

2.0

—

(44806420)

1.46

0.46

1.9

2.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

402

1.17

0.46

1.3

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

132

1438

0.91

0.45

1.3

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

0.61

0.45

1.8

2.0

4.6

2.9

ug/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.59

0.45

1.0

1.1

—

(44813793)

103

1.36

0.45

1.1

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

320

1.19

0.44

2.7

3.9

57.8

57.7

0.01

320

(3033799) Differential panel - Peritoneal fluid

1.37

0.44

1.9

2.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

229

1.23

0.43

1.3

1.2

—

(3044927) Protein electrophoresis panel - Urine

166

1.27

0.43

1.2

1.1

—

(3017569) Oxygen content in Arterial blood

1.41

0.43

1.5

2.8

—

(3013637) Mi-2 Ab [Presence] in Serum

1.61

0.43

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.61

0.43

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.61

0.43

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.61

0.43

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.56

0.42

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

265

2797

0.94

0.42

2.6

3.1

0.7

0.8

ug/l

0.32

195

1866

(44790048)

167

1.26

0.41

1.4

1.5

—

(44790049)

167

1.26

0.41

1.4

1.5

—

(44790047)

167

1.26

0.41

1.4

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

249

1.21

0.41

1.2

27.7

37.2

u/l

0.40

215

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

206

0.77

0.41

1.3

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.38

0.41

1.1

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

370

1.17

0.41

2.3

2.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.40

0.0

4.7

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.40

0.0

1.0

—

9.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.43

0.39

5.4

6.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.43

0.39

1.6

2.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

196

1.23

0.39

2.7

2.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.38

0.38

1.1

1.7

—

10.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.39

0.38

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1430

14114

1.04

0.37

6.6

5.6

40.3

39.8

mmol/mol

0.63

1333

13040

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

116

1.29

0.37

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1636

16513

0.96

0.36

14.5

10.1

26.4

26.0

u/l

0.49

1585

15920

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

168

0.77

0.35

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.35

1.5

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.35

1.5

2.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.31

0.35

1.2

—

(3025577) Chromium [Mass/volume] in Blood

0.62

0.35

1.8

2.0

1.9

ug/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

135

1.26

0.35

3.4

4.8

293.6

65.3

u/ml

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.30

0.33

1.2

1.3

37.2

56.2

—

(3042733) HLA Ab [Presence] in Serum

1.28

0.32

3.5

4.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.28

0.32

1.0

1.1

—

(4281824)

165

0.79

0.32

1.5

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

1446

14295

1.04

0.32

27.5

15.2

39.3

39.5

0.62

1037

10308

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

348

0.86

0.31

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

370

1.14

0.31

2.5

2.4

173.0

136.4

ug/min

0.19

226

(3043410) Blood group antigens tested for on Red Blood Cells

1.30

0.30

1.6

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

131

1228

1.07

0.30

2.8

2.7

66.8

66.4

ml/min/173m2

0.04

499

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.33

0.30

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

196

0.81

0.30

1.1

1.0

4.7

2.6

u/ml

—

(3025130) Human papilloma virus identified in Specimen

194

1.19

0.29

2.0

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

323

0.86

0.28

1.3

1.4

—

(44806118)

167

1.20

0.28

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.27

0.27

1.1

1.2

3.3

5.1

umol/l

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

322

0.87

0.27

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

322

0.87

0.27

1.3

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

309

1.13

0.27

1.6

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

321

0.87

0.26

1.3

1.4

—

(3037121) Protein [Mass/volume] in Urine

558

1.10

0.26

2.7

3.3

0.2

0.3

g/l

2.07

227

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

188

1.17

0.25

1.2

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.22

0.25

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

1.22

0.25

1.4

1.6

—

(3003338) MCHC [Mass/volume]

1340

13259

1.03

0.25

31.1

18.2

331.7

332.2

g/l

1.14

1325

13126

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

114

1.23

0.25

1.0

1.1

—

(21494434) Karyotype in Bone marrow

148

0.81

0.24

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

170

1.18

0.24

1.5

1.2

—

(40768806) Pleura Pathology biopsy report

170

1.18

0.24

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.28

0.24

1.0

1.4

—

(3048879) Bone marrow aspiration report

1.32

0.23

1.2

1.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

178

0.84

0.22

1.1

3.4

4.2

u/ml

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.21

0.0

2.1

—

0.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.21

0.0

1.1

—

4575.2

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

2.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.5

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.1

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.21

0.0

1.8

—

2.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

1.23

0.21

1.2

1.3

—

211.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.23

0.21

1.3

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

2.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

145

1.17

0.20

1.2

1.4

99017.5

134274.7

e6/l

0.16

102

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.22

0.20

1.3

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.22

0.20

1.2

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.20

0.19

1.7

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

302

0.89

0.19

1.9

1.3

—

(3005570) Glucose [Moles/volume] in Urine

174

1.15

0.19

1.7

2.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1.22

0.19

1.2

1.7

7.8

7.7

mmol/l

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.15

0.19

1.3

1.2

118.5

114.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

463

1.08

0.18

1.6

1.3

—

(40765096) Chromosome analysis panel by Banding

1.21

0.18

1.0

1.1

—

(3035880) pH of Pleural fluid

1.21

0.17

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

132

1266

1.05

0.17

1.5

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

110

1.18

0.17

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

129

1.16

0.17

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

129

1.16

0.17

1.3

1.4

12.4

11.9

mmol/l

—

(4211845)

0.71

0.16

3.6

2.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1642

16498

0.98

0.16

26.8

16.4

76.8

78.0

umol/l

0.59

1642

16491

(1617658) Protocol used for examination of sentinel lymph nodes

130

0.85

0.16

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

111

1.17

0.15

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

130

1.15

0.15

3.4

2.1

—

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.81

0.14

7.6

6.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

254

0.90

0.14

1.3

1.6

—

(3003694) ABO and Rh group [Type] in Blood

424

4166

1.02

0.14

1.5

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

414

1.06

0.12

5.8

4.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

279

1.08

0.11

1.1

0.1

2.3

u/ml

2.52

124

(3038026) Centromere Ab [Units/volume] in Serum

115

1.13

0.10

1.2

1.1

—

75.9

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

208

0.91

0.10

2.4

2.3

4082.1

25.4

u/ml

0.76

197

(3035933) Granulocytes/100 leukocytes in Blood

1.11

0.09

1.0

2.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.06

0.09

1.6

3.4

—

36.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

360

0.94

0.09

3.5

3.1

0.7

0.9

nmol/l

1.22

285

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

184

1.09

0.09

1.4

2.2

31.9

32.3

0.16

184

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.09

0.09

1.7

4.1

9.0

7.8

mg/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

204

1.08

0.08

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.81

0.08

1.0

1.2

—

(3006462) Nitrate [Presence] in Urine

0.81

0.08

3.6

2.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

146

1.10

0.08

1.6

2.2

—

(4146454)

164

0.91

0.08

2.7

—

(3000012) Reticulocyte production index

1.05

0.07

1.6

1.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.86

0.07

1.3

1.1

—

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.02

0.07

1.8

2.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

591

1.03

0.06

1.4

1.7

4.1

3.9

mg/l

0.03

418

(3003740) Influenza virus B Ag [Presence] in Specimen

266

1.05

0.06

1.2

1.1

—

(40761511) CBC panel - Blood by Automated count

1626

16291

0.99

0.05

21.0

13.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

167

1648

1.01

0.05

1.6

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

248

1.05

0.05

1.0

1.1

0.7

4.6

u/ml

3.96

128

(3000034) Microalbumin [Mass/volume] in Urine

130

1.08

0.04

2.2

3.1

38.4

40.8

mg/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

181

1831

0.99

0.04

4.7

4.3

31.2

32.5

0.78

129

1234

(3012441) Differential panel - Pleural fluid

170

1.06

0.04

1.5

1.3

—

(3045142) Bone marrow Pathology biopsy report

169

0.95

0.03

1.3

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

132

1.06

0.02

1.6

1.3

—

(40768795) Lymph node Pathology biopsy report

142

1.06

0.02

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

142

1.06

0.02

1.3

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

113

1.06

0.01

1.3

1.1

—

36.3

—

(3002256) Pathology report gross observation

200

1989

1.01

0.01

1.2

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

114

1.05

0.00

2.4

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

114

1.05

0.00

1.2

1.1

—

50.1

—

(3004775) Volume in Urine collected for unspecified duration

116

1.03

0.00

2.1

2.3

796.6

652.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

232

0.99

0.00

1.1

4.2

2.3

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

266

1.01

0.00

1.2

1.1

—

(40768441) Liver Pathology biopsy report

108

1.02

0.00

1.1

1.4

—

(3045788) Cell count panel - Pleural fluid

152

0.99

0.00

1.3

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

106

1.04

0.00

1.1

—

2.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

241

2413

1.00

0.00

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

239

1.00

0.00

1.0

1.1

0.4

2.0

u/ml

1.39

109

(3038177) Helicobacter pylori Ab [Presence] in Serum

242

0.99

0.00

1.5

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

285

0.98

0.00

1.8

1.3

216.8

265.4

u/ml

0.43

166

(3050129) First trimester maternal screen panel - Serum or Plasma

379

1.00

0.00

1.3

1.4

—

(4034850)

516

1.01

0.00

12.0

10.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

128

1.02

0.00

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

128

1.02

0.00

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

128

1.02

0.00

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

470

1.00

0.00

1.3

189.0

231.7

miu/ml

0.28

216

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.3

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

0.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.90

0.00

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

2.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1483.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.01

0.00

1.6

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(40768446) Kidney Pathology biopsy report

0.85

0.00

1.6

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.01

0.00

1.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.7

—

4.3

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

4.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.91

0.00

1.5

2.0

24.2

138.0

ug/l

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.01

0.00

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.01

0.00

1.6

—

(4038314)

0.00

0.0

1.3

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

2.7

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

2.0

—

1.5

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.5

—

(3017704) Immunofixation for Urine

1.01

0.00

1.1

1.5

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.0

—

394.4

—

(3015183) Erythrocyte sedimentation rate

0.96

0.00

1.1

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

2.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_HEMIPLE and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_HEMIPLE	2.657 [2.41, 2.93]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.197

During the follow-up period (1.1.1998 — 31.12.2019), 2893 out of 7556 females with G6_HEMIPLE died.

Males

Parameter	HR [95% CI]	p-value
G6_HEMIPLE	2.42 [2.19, 2.68]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 3188 out of 6891 males with G6_HEMIPLE died.

Mortality risk

Mortality risk for people of age

years, who have G6_HEMIPLE.

N-year risk	Females	Males
1	0.253%	0.489%
5	1.566%	2.915%
10	3.809%	6.952%
15	7.185%	13.236%
20	12.133%	21.79%

Relationships between endpoints

↥

Index endpoint: G6_HEMIPLE – Hemiplegia

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hemiplegia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints